Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 51
Filter
1.
Clin Biomech (Bristol, Avon) ; 65: 73-80, 2019 05.
Article in English | MEDLINE | ID: mdl-30991233

ABSTRACT

BACKGROUND: High flow nasal cannula therapy is a form of respiratory support which delivers high flow rates of heated, humidified gas to the nares via specialized cannula. Two primary mechanisms of action attributed to the therapy are the provision of positive airway pressure as well as clearance of CO2-rich exhaled gas from the upper airways. METHODS: Physiologically accurate nose-throat airway replicas were connected at the trachea to a lung simulator, where CO2 was supplied to mimic the CO2 content in exhaled gas. Cannula delivered either air, oxygen or heliox (80/20%volume helium/oxygen) to the replicas at flow rates ranging from 0 to 60 l/min. Five replicas and three cannulas were compared. Tracheal pressure and CO2 concentration were continuously measured. The lung simulator provided breaths with tidal volume of 500 ml and frequency of 18 breaths/min. Additional clearance measurements were conducted for tidal volume and breathing frequency of 750 ml and 27 breaths/min, respectively. FINDINGS: Cannula flow rate was the dominant factor governing CO2 concentration. Average CO2 concentration decreased with increasing cannula flow rate, but above 30 L/min this effect was less pronounced. Tracheal positive end-expiratory pressure increased with flow rate and was lower for heliox than for air or oxygen. A predictive correlation was developed and used to predict positive end-expiratory pressure for a given cannula size as a function of supplied flow rate and occlusion of the nares. INTERPRETATION: Compared with administration of air or oxygen, administration of heliox is expected to result in similar CO2 clearance from the upper airway, but markedly lower airway pressure.


Subject(s)
Cannula , Carbon Dioxide/metabolism , Helium/administration & dosage , Intubation , Oxygen Inhalation Therapy , Oxygen/administration & dosage , Adult , Female , Humans , Intubation/instrumentation , Intubation/methods , Male , Nose , Oxygen Inhalation Therapy/instrumentation , Oxygen Inhalation Therapy/methods
2.
Vet J ; 176(2): 170-6, 2008 May.
Article in English | MEDLINE | ID: mdl-17855133

ABSTRACT

The objective of this study was to evaluate the effect of local photodynamic therapy (PDT) with verteporfin on tumor growth inhibition of squamous cell carcinoma (SCC) in a murine model. SCC was implanted in 85 nude mice by subcutaneous injection of A-431 SCC cells. Treatment groups (10 mice/group) received an intra-tumoral injection of verteporfin dissolved in dimethyl sulfoxide (DMSO) or 5% dextrose solution at a dose of 0.01 or 0.1mg/cm3. Controls received only solvent, or no injectate. All groups received identical light illumination (100J/cm2). Relative change in tumor volume (RCTV) at day 30 was compared between groups using the Wilcoxon rank sum test (P< 0.05). Local PDT with verteporfin at a dose of 0.1mg/cm3 resulted in significantly lower RCTV at day 30 compared to controls. Choice of solvent (DMSO versus D5W) did not affect the results. Local PDT may be an effective adjunctive therapy for the treatment of periocular equine SCC.


Subject(s)
Carcinoma, Squamous Cell/veterinary , Eye Neoplasms/veterinary , Horse Diseases/drug therapy , Photochemotherapy/veterinary , Animals , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/pathology , Eye Neoplasms/drug therapy , Eye Neoplasms/pathology , Female , Histocytochemistry , Horse Diseases/pathology , Horses , Humans , Injections, Intralesional , Mice , Mice, Nude , Photochemotherapy/methods , Photosensitizing Agents/administration & dosage , Porphyrins/administration & dosage , Random Allocation , Specific Pathogen-Free Organisms , Verteporfin , Xenograft Model Antitumor Assays
3.
Vet Ophthalmol ; 10(4): 216-21, 2007.
Article in English | MEDLINE | ID: mdl-17565553

ABSTRACT

A 5-year-old, neutered male Domestic Short-haired cat was referred with a 5-month history of anterior uveitis and cataract in the right eye. Clinical examination confirmed anterior uveitis and immature cataract in the right eye and chorioretinitis in the left eye. Ocular ultrasound showed a retinal detachment in the right eye. Diagnostic testing revealed elevated serum titers for Toxoplasma gondii. Anterior uveitis in the right eye and chorioretinitis in the left eye progressed, resulting in blindness despite a 21-day course of clindamycin and aggressive topical medical management of uveitis. The right eye was enucleated and histopathologic evaluation of the globe revealed panuveitis and multiple organisms morphologically consistent with Histoplasma capsulatum. Systemic treatment with itraconazole was initiated. Vision returned after 3 months of treatment and complete resolution of the retinal hemorrhages with formation of a flat chorioretinal scar was noted after 6 months of therapy. Itraconazole was discontinued 7 months after starting therapy, at which time the funduscopic appearance of the chorioretinal scar had remained static for 1 month. The cat has remained visual without evidence of disease progression for 6 months following discontinuation of itraconazole.


Subject(s)
Cat Diseases/diagnosis , Histoplasmosis/veterinary , Panuveitis/veterinary , Toxoplasmosis, Ocular/veterinary , Animals , Cat Diseases/blood , Cat Diseases/drug therapy , Cat Diseases/microbiology , Cat Diseases/parasitology , Cats , Diagnosis, Differential , Eye Enucleation/veterinary , Histoplasma/isolation & purification , Histoplasmosis/complications , Histoplasmosis/diagnosis , Male , Panuveitis/complications , Panuveitis/diagnosis , Retinal Detachment/complications , Retinal Detachment/diagnosis , Retinal Detachment/veterinary , Toxoplasma/isolation & purification , Toxoplasmosis, Ocular/complications , Toxoplasmosis, Ocular/diagnosis , Uveitis, Anterior/complications , Uveitis, Anterior/diagnosis , Uveitis, Anterior/veterinary
4.
Res Vet Sci ; 83(3): 355-9, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17367832

ABSTRACT

Cryopreserved equine ocular squamous cell carcinoma (SCC) was inoculated subcutaneously into 15 athymic nude and 15 SCID mice. Xenotransplantation resulted in tumor growth in two athymic nude mice and 1 SCID mouse. Histological appearance and immunohistochemical characterization using cytokeratin 5/6 markers and p53 markers of the tumor grown in mice was in full accord with the original equine tumors. No evidence of metastasis was noted in any mouse. This model may serve as a relevant in vivo model for studying the biology of equine ocular SCC and for the testing of new therapeutic modalities.


Subject(s)
Carcinoma, Squamous Cell/veterinary , Cryopreservation/veterinary , Graft Survival/physiology , Horse Diseases/pathology , Transplantation, Heterologous , Animals , Biomarkers, Tumor , Carcinoma, Squamous Cell/pathology , Horses , Mice , Mice, Nude , Mice, SCID , Neoplasms, Experimental
5.
Invest Ophthalmol Vis Sci ; 42(3): 653-9, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11222523

ABSTRACT

PURPOSE: To test the hypothesis that beneficial effects of Cyclosporin A (CsA; Sandimmune; Sandoz, Basel, Switzerland) in treating keratoconjunctivitis sicca (KCS) include an effect on the mucin-producing conjunctival goblet cells independent of CsA's effect on lacrimation. METHODS: Keratoconjunctivitis sicca was induced bilaterally in six dogs after removal of orbital and nictitans lacrimal glands. Two weeks after induction of KCS, either 2% CsA or vehicle was applied twice daily to each surgically altered eye until 6 weeks after KCS induction. Eyes of three control dogs without surgically altered eyes were treated twice daily with vehicle only. Incisional biopsy specimens of ventral fornix conjunctiva were collected before gland removal (baseline) and at 2, 4, and 6 weeks after KCS induction. At each sampling time, eyes were photographed, and color images were subsequently graded for degree of conjunctivitis and characteristics of ocular discharge. Intracellular mucin stores in conjunctival epithelia were estimated using computer-assisted morphometry of biopsy specimen cross sections, and clinical and morphometric findings were correlated. RESULTS: Lacrimal gland removal resulted in induction of KCS in dogs by 2 weeks, with mean Schirmer tear test (STT) values of 5 mm/min or less occurring in surgically altered eyes compared with STT values of 22.5 mm/min before surgery and 22.9 mm/min in unaltered control eyes at 2 weeks. In surgically altered eyes, STTs remained low during the 6-week study, independent of topical treatment. Intracellular mucin stores were quantified from conjunctival samples collected from each eye at baseline and 2, 4, and 6 weeks. At 4 and 6 weeks (after 2 and 4 weeks of topical treatment), intraepithelial mucin quantities were significantly greater (P: < 0.05) in CsA-treated KCS eyes (14.4 and 13.1 microm(2)/microm, respectively) compared with pretreatment KCS (7.4 microm(2)/microm) eyes and vehicle-treated KCS eyes (7.3 and 8.5 microm(2)/microm, respectively). KCS eyes treated with CsA had lower conjunctivitis and ocular discharge scores than did vehicle-treated KCS eyes. CONCLUSIONS: Topical 2% CsA restored in vivo conjunctival mucin stores to control levels over a 4-week period, determined by computer-assisted morphometry of sequential conjunctival biopsy specimens from eyes of dogs with surgically induced KCS. Degree of conjunctivitis and severity of mucus discharge were decreased in KCS eyes treated with CsA. Because lacrimal tissues were removed from animals in this study, conjunctival responses occurred independent of lacrimogenic effect(s). These results indicate that restoration of conjunctival goblet cell mucin production, i.e., the balance between synthesis and secretion of mucin glycoproteins, may play an important role in the beneficial effect of CsA in treating KCS.


Subject(s)
Conjunctiva/drug effects , Conjunctiva/metabolism , Cyclosporine/pharmacology , Immunosuppressive Agents/pharmacology , Keratoconjunctivitis Sicca/metabolism , Mucins/metabolism , Administration, Topical , Animals , Cyclosporine/administration & dosage , Dogs , Immunosuppressive Agents/administration & dosage , Keratoconjunctivitis Sicca/drug therapy , Keratoconjunctivitis Sicca/pathology , Lacrimal Apparatus/surgery , Models, Animal , Ophthalmic Solutions
6.
J Biol Chem ; 276(3): 2069-74, 2001 Jan 19.
Article in English | MEDLINE | ID: mdl-11035044

ABSTRACT

The skeletal muscle calcium release channel, ryanodine receptor, is activated by calcium-free calmodulin and inhibited by calcium-bound calmodulin. Previous biochemical studies from our laboratory have shown that calcium-free calmodulin and calcium bound calmodulin protect sites at amino acids 3630 and 3637 from trypsin cleavage (Moore, C. P., Rodney, G., Zhang, J. Z., Santacruz-Toloza, L., Strasburg, G., and Hamilton, S. L. (1999) Biochemistry 38, 8532-8537). We now demonstrate that both calcium-free calmodulin and calcium-bound calmodulin bind with nanomolar affinity to a synthetic peptide matching amino acids 3614-3643 of the ryanodine receptor. Deletion of the last nine amino acids (3635-3643) destroys the ability of the peptide to bind calcium-free calmodulin, but not calcium-bound calmodulin. We propose a novel mechanism for calmodulin's interaction with a target protein. Our data suggest that the binding sites for calcium-free calmodulin and calcium-bound calmodulin are overlapping and, when calcium binds to calmodulin, the calmodulin molecule shifts to a more N-terminal location on the ryanodine receptor converting it from an activator to an inhibitor of the channel. This region of the ryanodine receptor has previously been identified as a site of intersubunit contact, suggesting the possibility that calmodulin regulates ryanodine receptor activity by regulating subunit-subunit interactions.


Subject(s)
Calcium/metabolism , Calmodulin/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , Amino Acid Sequence , Binding Sites , Fluorescence , Molecular Sequence Data , Protein Binding , Ryanodine Receptor Calcium Release Channel/chemistry , Tryptophan/chemistry
7.
Curr Eye Res ; 23(6): 435-42, 2001 Dec.
Article in English | MEDLINE | ID: mdl-12045893

ABSTRACT

PURPOSE: Herpes simplex virus type 1 is a major cause of stromal keratitis and blindness in humans. Understanding of the role of host genes in the pathogenesis of herpes stromal keratitis is limited. We used a transgenic mouse model to examine the effect of a host gene, Hox A5 (which binds to the TAATGARAT sequence in the promoter regions of HSV-1 immediate early genes and increases HSV-1 replication), on the pathogenesis of HSV-1 induced stromal keratitis. METHODS: Corneas of wildtype and Hox A5 transgenic mice were infected with HSV-1 strain F following corneal scarification. Clinical severity of keratitis was evaluated using slit-lamp biomicroscopy. Histologic severity of keratitis was determined by light microscopic evaluation and by computerized morphometry. Ocular viral replication was measured via plaque assay. RESULTS: Clinical lesions of stromal keratitis were more severe at 17 and 23 days post infection in Hox A5 transgenic mice than in wildtype mice. Histological evaluation and morphometric analysis confirmed that keratitis lesions were more severe in the transgenic mice. HSV-1 replication was approximately100-fold greater in the corneas of transgenic mice than in wildtype mice. CONCLUSIONS: Our results demonstrate that a host gene (Hox A5) can increase ocular replication of HSV-1 and alter the pathogenesis of herpetic stromal keratitis.


Subject(s)
Corneal Stroma/virology , Herpesvirus 1, Human/physiology , Homeodomain Proteins/genetics , Keratitis, Herpetic/genetics , Keratitis, Herpetic/virology , Phosphoproteins , Virus Replication/genetics , Animals , Corneal Stroma/pathology , Gene Expression/physiology , Keratitis, Herpetic/pathology , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Transgenic , RNA, Viral/analysis , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors
8.
J Cell Physiol ; 184(3): 400-8, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10911372

ABSTRACT

Cyclosporine is a potent immunosuppressant used in the treatment of ulcerative colitis and keratoconjunctivitis sicca. Neither the etiologies of these diseases nor the mechanism by which cyclosporine exerts its therapeutic effect is well understood. Since both diseases are linked by a common decrease in mucin-filled goblet cells, this study tests a hypothesis that cyclosporine acts directly on goblet cells to promote their differentiation and production of secretory mucins. The HT29-18N2 human colon adenocarcinoma cell line, which is capable of forming monolayers of well-differentiated goblet cells, was used as a model system. Cyclosporine induced a dose-dependent increase in intracellular mucin stores. A 2-week exposure to 1 microM cyclosporine resulted in an average increase in mucin volume of 94%. This increase resulted from both a higher percentage of cells with mucin stores and an increased volume of mucin per cell. PSC-833, a nonimmunosuppressive analog of cyclosporine, also increased mucin production. The intracellular accumulation of mucin was not a result of reduced secretion, since the time required for the release of pulse-radiolabeled glycoproteins was similar for both control and cyclosporine-treated monolayers. The effect of cyclosporine was not mediated by the drug's previously documented abilities to decrease cellular proliferation rates, inhibit calmodulin, antagonize prolactin receptor binding, or modulate prostaglandin production.


Subject(s)
Cyclosporine/pharmacology , Goblet Cells/cytology , Goblet Cells/drug effects , Mucins/metabolism , Calmodulin/antagonists & inhibitors , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Line , Colitis, Ulcerative/drug therapy , Cyclosporins/pharmacology , Glycoproteins/metabolism , Goblet Cells/metabolism , Humans , Immunosuppressive Agents/pharmacology , Keratoconjunctivitis Sicca/drug therapy , Prolactin/antagonists & inhibitors , Prostaglandin-Endoperoxide Synthases/metabolism
9.
Phys Rev Lett ; 85(26 Pt 1): 5511-4, 2000 Dec 25.
Article in English | MEDLINE | ID: mdl-11136034

ABSTRACT

We present measurements of absorption by the 21 cm hyperfine transition of neutral hydrogen toward radio sources at substantial look-back times. These data are used in combination with observations of rotational transitions of common interstellar molecules to set limits on the evolution of the fine structure constant: alpha/ alpha<3.5x10(-15) yr(-1), to a look-back time of 4.8 Gyr. In the context of string theory, the limit on the secular evolution of the scale factor of the compact dimensions, R, is &Rdot/ R<10(-15) yr(-1). Including terrestrial and other astronomical measurements places 2sigma limits on slow oscillations of R from the present to the epoch of cosmic nucleosynthesis, just seconds after the big bang, of DeltaR /R<10(-5).

10.
Vet Ophthalmol ; 3(2-3): 57-63, 2000.
Article in English | MEDLINE | ID: mdl-11397284

ABSTRACT

Five horses presented with unilateral pink, smooth, nonulcerated conjunctival masses with histologic features characteristic of inflammatory pseudotumors, i.e. proliferative inflammatory lesions clinically resembling true neoplasia. Although causes for the inflammatory lesions were not determined, based on the presence histologically of mononuclear (predominantly lymphocytic) inflammatory cell infiltrates and the absence of infectious agents, parasites or foreign bodies, an immune-mediated pathogenesis was suspected. Affected horses ranged from 5 to 8 years of age with no apparent breed or sex predilection. Conjunctival lesions were nodular in two cases and relatively flat and more diffuse in three cases. Third eyelid lesions were present in three cases and two affected eyes had corneal involvement. Based on findings from these five cases, the prognosis for equine conjunctival pseudotumors appears to be good when lesions are treated by partial or complete surgical excision, local administration of anti-inflammatory agents, or a combination of surgery and anti-inflammatory therapy.

11.
Vet Ophthalmol ; 3(2-3): 153-156, 2000.
Article in English | MEDLINE | ID: mdl-11397298

ABSTRACT

The objective of this study was to describe method of placement, and frequency and severity of complications associated with a subpalpebral lavage system placed in the medial aspect of the equine inferior eyelid. The inferomedial subpalpebral lavage (ISPL) tube is positioned deep in the medial aspect of the inferior conjunctival fornix so that the footplate lies flat between the lower eyelid and the anterior surface of the nictitans. Retrospective data from the placement of 92 ISPL systems placed in 86 horses during a 31-month period were examined. Tube placement was performed using sedation and regional anesthesia only in 59% of horses. The median duration of tube placement was 19 days (range: 1-61 days). Seventy-one horses were treated for up to 55 days following discharge from hospital with an ISPL tube in place. No complications were reported with 59% of ISPL systems. Non-ocular complications were found in 38% of ISPL systems and included tube displacement from the conjunctival fornix (18%), suture loss requiring resuturing of the system to the horse's head (14%), and damage necessitating replacement of the injection port (6%). Ocular complications were recorded in 3% of horses and were limited to inferior eyelid swelling. Vision was retained in 88% of horses. The ISPL system is easily and safely placed, and well tolerated for extended periods. It appears to be associated with infrequent and minor complications when compared with placement of subpalpebral lavage tubes in the superior eyelid.

12.
Vet Ophthalmol ; 3(2-3): 201-206, 2000.
Article in English | MEDLINE | ID: mdl-11397303

ABSTRACT

A case of malignant melanoma originating from the conjunctiva of a horse is reported. The tumor exhibited locally aggressive behavior as evidenced clinically by recurrence following two treatment episodes including surgical excision on each occasion and one application of cryotherapy. The orbit was subsequently exenterated and histologically malignant conjunctival melanoma was confirmed. Histopathologic features included variable pigmentation with amelanotic sites demonstrating marked cellular and nuclear pleomorphism with high numbers of mitotic figures. Cords of neoplastic cells invaded the sclera and cornea. Following exenteration, the horse exhibited no recurrence of the tumor for five years before being lost to follow-up. To our knowledge, this is the first report of primary malignant conjunctival melanoma in a horse.

13.
J Zoo Wildl Med ; 30(3): 423-30, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10572869

ABSTRACT

A 5-wk-old female dromedary camel (Camelus dromedarius) was clinically diagnosed with bilateral corneal dermoids, incomplete congenital cataracts, a left persistent hyaloid artery (PHA), and a ventricular septal defect (VSD). The corneal dermoids were removed by lamellar keratectomy, and vision improved in the left eye. Thirteen months after dermoid surgery, the calf was presented for enlargement of the right eye. Glaucoma was confirmed in the right eye, and corneal fibrosis and cataract were noted in the left eye. Persistence of the VSD was confirmed by cardiac ultrasonography. The calf was euthanized, and necropsy findings confirmed VSD. Histopathologic examination revealed bilateral corneal thinning and fibrosis, cataracts with retrolental fibroplasia, and retinal dysplasia. Additional changes in the right globe were anterior segment dysgenesis, ruptured lens capsule, chronic phacoclastic uveitis, and retinal separation. The PHA was confirmed in the left eye.


Subject(s)
Camelus/abnormalities , Corneal Diseases/veterinary , Dermoid Cyst/veterinary , Eye Abnormalities/veterinary , Eye Neoplasms/veterinary , Heart Septal Defects, Ventricular/veterinary , Animals , Arteries/abnormalities , Cataract/congenital , Cataract/veterinary , Cornea/pathology , Corneal Diseases/congenital , Corneal Diseases/surgery , Dermoid Cyst/congenital , Dermoid Cyst/surgery , Euthanasia/veterinary , Eye Abnormalities/complications , Eye Neoplasms/congenital , Eye Neoplasms/surgery , Fatal Outcome , Female , Glaucoma/diagnosis , Glaucoma/veterinary , Heart Septal Defects, Ventricular/complications , Heart Septal Defects, Ventricular/diagnostic imaging , Lens, Crystalline/pathology , Retinal Detachment/veterinary , Retinal Dysplasia/veterinary , Ultrasonography , Vitreous Body/blood supply
14.
Biochemistry ; 38(26): 8532-7, 1999 Jun 29.
Article in English | MEDLINE | ID: mdl-10387100

ABSTRACT

The skeletal muscle Ca2+ release channel (RYR1) is regulated by calmodulin in both its Ca2+-free (apocalmodulin) and Ca2+-bound (Ca2+ calmodulin) states. Apocalmodulin is an activator of the channel, and Ca2+ calmodulin is an inhibitor of the channel. Both apocalmodulin and Ca2+ calmodulin binding sites on RYR1 are destroyed by a mild tryptic digestion of the sarcoplasmic reticulum membranes, but calmodulin (either form), bound to RYR1 prior to tryptic digestion, protects both the apocalmodulin and Ca2+ calmodulin sites from tryptic destruction. The protected sites are after arginines 3630 and 3637 on RYR1. These studies suggest that both Ca2+ calmodulin and apocalmodulin bind to the same or overlapping regions on RYR1 and block access of trypsin to sites at amino acids 3630 and 3637. This sequence is part of a predicted Ca2+ CaM binding site of amino acids 3614-3642 [Takeshima, H., et al. (1989) Nature 339, 439-445].


Subject(s)
Calcium/metabolism , Calmodulin/metabolism , Muscle, Skeletal/metabolism , Ryanodine Receptor Calcium Release Channel/metabolism , Animals , Apoproteins/chemistry , Apoproteins/metabolism , Binding Sites , Calmodulin/chemistry , Hydrolysis , Muscle, Skeletal/chemistry , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Ryanodine Receptor Calcium Release Channel/chemistry , Sulfur Radioisotopes , Trypsin/metabolism
15.
Equine Vet J ; 30(5): 366-72, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9758092

ABSTRACT

Traumatic keratouveitis in horses is characterised by a unilateral, aseptic, vascularising keratitis accompanied by moderate to severe anterior uveitis. In a series of 9 cases of post traumatic keratouveitis, topical and systemic nonsteroidal drugs and atropine were used to control the anterior uveitis while allowing spontaneous corneal healing. Among the 9 cases reported, 6 affected eyes previously treated with local corticosteroids took significantly longer to resolve when compared to 3 eyes in which corticosteroids had not been administered. It was concluded that, in cases of equine post traumatic keratouveitis, locally administered corticosteroids inhibit healing of damaged corneal stroma and, by prolonging the keratitis, perpetuate the concurrent anterior uveitis.


Subject(s)
Corneal Injuries , Eye Injuries/veterinary , Horse Diseases/etiology , Keratitis/veterinary , Uveitis, Anterior/veterinary , Administration, Topical , Adrenal Cortex Hormones/administration & dosage , Adrenal Cortex Hormones/therapeutic use , Animals , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Atropine/administration & dosage , Atropine/therapeutic use , Drug Therapy, Combination , Eye Injuries/complications , Female , Horse Diseases/drug therapy , Horses , Keratitis/drug therapy , Keratitis/etiology , Male , Mydriatics/administration & dosage , Mydriatics/therapeutic use , Ophthalmic Solutions , Uveitis, Anterior/drug therapy , Uveitis, Anterior/etiology
17.
Am J Vet Res ; 59(7): 856-8, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9659551

ABSTRACT

OBJECTIVE: To determine whether feline herpesvirus 1 (FHV-1) DNA is in the corneas of clinically normal cats and cats with eosinophilic keratitis or corneal sequestration. SAMPLE POPULATION: Corneal biopsy specimens obtained from cats referred for treatment of corneal sequestration or eosinophilic keratitis. PROCEDURE: Corneal scraping or keratectomy specimens collected from clinically normal cats, cats with eosinophilic keratitis, and cats with corneal sequestration were evaluated for FHV-1 DNA by use of polymerase chain reaction (PCR). DNA was extracted from the tissue, and 1 microgram was assayed for FHV-1 by use of a single-round (40 cycles) PCR assay with primers directed at a 322-bp region of the thymidine kinase gene. Polymerase chain reaction positivity for clinically normal and affected cats of various breeds was compared by chi 2 analysis at alpha = 0.05. RESULTS: The FHV-1 DNA was detected in 5.9% (1/17) of corneas from clinically normal cats, in 55.1% (86/156) of corneal sequestra, and in 76.3% (45/59) of scraping specimens from cats with eosinophilic keratitis. Prevalence was significantly (P < 0.001) greater for cats with corneal sequestration or eosinophilic keratitis than for clinically normal cats. For cats with corneal sequestration, prevalence of FHV-1 DNA was significantly lower in Persian and Himalayan, compared with domestic shorthair and longhair breeds. CONCLUSION: Data strongly imply involvement of FHV-1 in the pathogenesis of eosinophilic keratitis and corneal sequestration. In Persian and Himalayan breeds, however, other nonviral factors also appear to be involved. CLINICAL RELEVANCE: Feline herpesvirus 1 must be considered when treating cats with corneal sequestration or eosinophilic keratitis.


Subject(s)
Cat Diseases/virology , Cornea/virology , Corneal Diseases/virology , DNA, Viral/analysis , Herpesviridae Infections/veterinary , Herpesviridae/isolation & purification , Keratitis/veterinary , Animals , Cat Diseases/pathology , Cats , Cornea/pathology , Corneal Diseases/pathology , DNA Primers , Herpesviridae/genetics , Herpesviridae Infections/pathology , Keratitis/pathology , Keratitis/virology , Polymerase Chain Reaction
18.
J Appl Microbiol ; 84(4): 607-18, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9633659

ABSTRACT

A complex seven species model community, including bacteria and fungi, was selected from organisms isolated from the walls of an industrial flowing water system. Growth rates of the species were determined in single and mixed batch culture growth. The rates were found to be significantly higher in mixed culture for Pseudomonas alcaligenes and Flavobacterium indologenes and higher in single culture for Xanthomonas maltophilia, Rhodotorula glutinis and Fusarium solani, whereas no significant difference was recorded for Alcaligenes denitrificans and Fusarium oxysporum. All species attached to PVC in single and mixed culture to form biofilms. Xanthomonas maltophilia, Alc. denitrificans, Ps. alcaligenes and F. solani biofilm cell densities cm-2 were significantly higher than attachment of the component species in mixed culture. Statistical analyses showed a significant difference in rate of colonization between single and mixed cultures for some species. No significant difference was noted between mixed culture cell densities cm-2 at laminar flows of Reynolds number 2.7 and 5.4.


Subject(s)
Biofilms/growth & development , Fungi/physiology , Gram-Negative Bacteria/physiology , Gram-Positive Bacteria/physiology , Bacillus/growth & development , Bacillus/isolation & purification , Bacillus/physiology , Fungi/growth & development , Fungi/isolation & purification , Gram-Negative Bacteria/growth & development , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/growth & development , Gram-Positive Bacteria/isolation & purification , Microscopy, Electron, Scanning , Time Factors , Water Microbiology
19.
Vet Ophthalmol ; 1(2-3): 171-174, 1998.
Article in English | MEDLINE | ID: mdl-11397228

ABSTRACT

An eight-year-old neutered male diabetic Cardigan Welsh Corgi was presented for bilateral mature cataracts. Phacoemulsification and intraocular lens implantation were performed routinely, and recovery was uneventful for several months except for lipemic aqueous flare which gradually resolved during the postoperative period. Five months following surgery the owner presented the dog for decreased vision. White retinal deposits were visualized ophthalmoscopically. Serum analysis revealed that the dog was concurrently markedly hyperlipemic. The patient's diet was changed from a high- to a low-fat diet, following which diabetes control improved, hyperlipemia resolved, and the retinal deposits decreased markedly in size. The retinal deposits seen ophthalmoscopically are presumed to be lipid based upon their association with marked hyperlipemia, and the concurrent resolution of hyperlipemia and the fundic lesions.

20.
Vet Clin North Am Small Anim Pract ; 27(5): 1011-66, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9326967

ABSTRACT

Review of the functional anatomy of ocular adnexal tissues is followed by presentation of surgical procedures aimed at correcting conditions of the eyelids, conjunctiva, and third eyelids of small animals. Procedures used effectively by the primary author are described in detail including instances where combination procedures may be indicated. Some newer, recently described techniques are also briefly discussed. Illustrations of applied anatomy and multiple surgical techniques are provided by illustrator and coauthor Dr. Gheorghe Constantinescu. References are given to encourage readers to further explore alternative techniques focusing on the surgical correction of adnexal diseases of dogs and cats.


Subject(s)
Conjunctiva/surgery , Eyelids/surgery , Nictitating Membrane/surgery , Ophthalmologic Surgical Procedures/veterinary , Surgery, Veterinary/methods , Animals , Cat Diseases/surgery , Cats , Conjunctival Diseases/surgery , Conjunctival Diseases/veterinary , Conjunctival Neoplasms/surgery , Conjunctival Neoplasms/veterinary , Dog Diseases/surgery , Dogs , Eyelid Diseases/surgery , Eyelid Diseases/veterinary , Eyelid Neoplasms/surgery , Eyelid Neoplasms/veterinary , Surgery, Veterinary/instrumentation , Suture Techniques/veterinary , Sutures/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...